Cannabis Bioscience International Holdings (CBIH) Debt Ratio (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Debt Ratio across 4 years of filings, most recently posting 171.04 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 171.04, up 688.95% year-over-year; the trailing twelve-month figure through Feb 2026 was 171.04 (up 688.95% YoY), and the FY2025 annual result was 8.28, up 89.9% from the prior year.
• Debt Ratio came in at 171.04 for Q1 2026 at Cannabis Bioscience International Holdings, up from 11.93 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 171.04 in Q1 2026 to a low of 2.57 in Q4 2023.
• The 4-year median for Debt Ratio is 7.6 (2024), against an average of 23.18.
• Across the five-year window, Debt Ratio fell 28.34% in 2024 and surged 694.13% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Debt Ratio stood at 2.57 in 2023, then surged by 195.75% to 7.6 in 2024, then surged by 57.09% to 11.93 in 2025, then soared by 1333.35% to 171.04 in 2026.
• The last three Debt Ratio figures came in at 171.04 (Q1 2026), 11.93 (Q4 2025), and 13.17 (Q3 2025), per Business Quant data.